期刊文献+

Shh信号通路在肝癌中的表达及与β-catenin的关系 被引量:2

Expression of sonic hedgehog pathway in hepatocellular carcinoma and its relation with β-catenin
下载PDF
导出
摘要 目的探讨原发性肝细胞癌(Hepatocellular Carcinoma, HCC)中 Sonic Hedgehog(Shh)信号通路基因和β-catenin的表达情况及其临床意义。方法采用免疫组织化学方法对 49 例 HCC 和相应癌旁肝组织中Gli1和β-catenin蛋白表达,荧光定量PCR检测2个肝癌细胞系和正常肝细胞中相应基因mR-NA的表达情况。结果免疫组化染色与 RT-PCR 示 Gli1 在 HCC 组织中的阳性表达率为 77.56%,而癌旁肝组织为40.82%,两者差异具有显著意义(P < 0.05)。β-catenin蛋白在HCC中的表达显著高于癌旁肝组织(P < 0.05),且与Gli1的表达呈正相关(r = 0.594,P = 0.000)。Gli1和β-catenin mRNA在肝癌细胞株中高表达,在正常肝细胞中低表达(P < 0.05)。结论 Gli1 和β-catenin 在肝癌细胞中均过度表达,可能协同作用促进肝癌细胞异常增殖,参与HCC的发生和发展。 Objective To study the expression of Glil in HCC and its relationship with the expression of β-catenin. Methods The protein and mRNA expression of Glil were detected by immunohistocbemistry and RT-PCR respectively in 49 cases of HCC tissues and corresponding adjacent liver tissues. Results The positive staining rate of Glil in HCC tissues was significantly higher than in the adjacent tumor tissues (77.56% vs 40.82%, P 〈 0.05). The expression of β-catenin in HCC was higher than in adjacent tumor tissues(69.39% vs 51.02%). There was a significant positive correlation between the expression of Glil and β-catenin(r = 0.594, P = 0.000). Conclusion The over-expression of Glil may play a crucial role in occurrence and progress of HCC by upregulating β-catenin, which leads to the abnormal proliferation of HCC cells.
出处 《现代消化及介入诊疗》 2012年第4期185-188,共4页 Modern Interventional Diagnosis and Treatment in Gastroenterology
基金 广东省自然科学基金(10451051501005740) 南方医科大学附属南方医院院长基金(2008C025)
关键词 肝细胞癌 Sonic HEDGEHOG信号通路 表达 Hepatocellular carcinoma Sonic hedgehog signaling pathway Expression
  • 相关文献

参考文献13

  • 1Parkin DM, Bray F, Ferlay J, et al. Estimating the world cancer bur- den: Globocan 2000. Int J Cancer, 2001,94: 153-156.
  • 2He J, Gu D, Wu X, et al. Major causes of death among men and women in China. N Engl J Meal, 2005,353:1124-1134.
  • 3Cohen MM. The hedgehog signaling network. Am J Med Genet, 2003,123A(1):5-28.
  • 4Reya T, Clevers I-L Wnt signalling in stem cells and cancer. Nature, 2005,434:843-850.
  • 5梁燕,王新颖,彭亮,许岸高,王伟飞,苏宁,陈楚弟,姜泊.ABCG2在大肠癌中的表达及其对预后的影响[J].现代消化及介入诊疗,2011,16(4):260-266. 被引量:4
  • 6Ma X, Sheng T, Zhang Y, et al. Hedgehog signaling is activated in subsets of esophageal cancers. Int J Cancer, 2006,118:139-148.
  • 7Mullor JL, Sanchez P, Altaba AR. Pathways and consequences: Hedgehog signaling in human disease. Trends Cell Biol, 2002,12: 562-569.
  • 8Ruizi Altaba A, Sanchez P, Dahmane N. Gli and hedgehog in can- cer: mmours, embryos and stem cells. Nat Rev Cancer, 2002,2:361- 372.
  • 9Berman DM, Karhadkar SS, Maitra A, et al. Widespread require- ment for Hedgehog ligand stimulation in growth of digesstive tract tumors. Nature, 2003,425(6960):846-851.
  • 10Cheng WT, Xu K, Tian DY, et al. Role of Hedgehog signaling path- way in proliferation and invasiveness of hepatocellular carcinoma cells. Int J Oncol, 2009,34:829-836.

二级参考文献26

  • 1Rocchi E, Khodjakov A, Volk EL, et al. The product of the ABC half-transporter gene ABCG2 (BCRP/MXR/ABCP) is expressed in the plasma membrane. Biochem Biophys Res Commun, 2000,271: 42-46.
  • 2Doyle LA, Ross DD. Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2). Oncogene, 2003,22: 7340-7358.
  • 3Miyake K, Mickley L, Litman T, et al. Molecular cloning of cDNAs which are highly overexpressed in mitoxantrone-resistant cells: demonstration of homology to ABC transport genes. Cancer Res, 1999,59:8-13.
  • 4Zhou S, Schuetz JD, Bunting KD, et al. The ABC transporter Bcrpl/ ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype. Nat Med, 2001,7: 1028-1034.
  • 5Krishnamurthy P, Ross DD, Nakanishi T, et al. The stem cell marker Bcrp/ABCG2 enhances hypoxic cell survival through interactions with heme. J Biol Chem, 2004,279:24218-24225.
  • 6Benderra Z, Faussat AM, Sayada L, et al. Breast cancer resistance protein and P-glycoprotein in 149 adult acute myeloid leukemias. Clin Cancer Res, 2004,10:7896-7902.
  • 7Yoh K, Ishii G, Yokose T, et al. Breast cancer resistance protein impacts clinical outcome in platinum-based chemotherapy for ad- vanced non-small cell lung cancer. Clin Cancer Res, 2004,10:1691- 1697.
  • 8Kim YH, Ishii G, Goto K, et al. Expression of breast cancer resistance protein is associated with a poor clinical outcome in patients with small-cell lung cancer. Lung Cancer, 2009,65:105-111.
  • 9Tsunoda S, Okumura T, Ito T, et al. ABCG2 expression is an inde- pendent unfavorable prognostic factor in esophageal squamous cell carcinoma. Oncology, 2006,71(3-4):251-258.
  • 10Jin Y, Bin ZQ, Qiang H, et al. ABCG2 is related with the grade of glioma and resistance to mitoxantone, a chemotherapeutic drug for glioma. J Cancer Res Clin Oncol, 2009,135:1369-1376.

共引文献3

同被引文献16

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部